Condition
Tolerance clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Tolerance clinical trials that are recruiting, at sites in 3 countries (most in United States (3), France (1), Pakistan (1)). By phase: Phase 1/2 (1), Early Phase 1 (1), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest Tolerance clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Venetoclax added to reduced-intensity conditioning for combined stem cell and kidney transplant | Early Phase 1 | Boston, Massachusetts | Recruiting | Jan 22, 2026 |
| Identifying factors affecting tolerance of ureteral double-J stents | — | Amiens | Recruiting | Feb 7, 2025 |
| Effects of Ertugliflozin on liver fat and diabetes control in patients with fatty liver disease | Phase 4 | Peshawar, KPK | Recruiting | Dec 9, 2022 |
| Using a special airway device to treat sleep apnea in children with weak muscles | — | Ann Arbor, Michigan | Recruiting | Sep 2, 2022 |
| Combined kidney and blood stem cell transplant from a sibling donor | Phase 1/2 | Los Angeles, California | Recruiting | Oct 16, 2018 |
All recruiting trials (5)
-
Venetoclax added to reduced-intensity conditioning for combined stem cell and kidney transplant
This trial tests whether adding venetoclax to a reduced-intensity conditioning regimen is safe for adults with blood cancers who are receiving a combined stem cell and kidney transplant from a matched or partially matched donor.
-
Identifying factors affecting tolerance of ureteral double-J stents
This study is trying to find out what makes it hard for people to tolerate ureteral double-J stents so that doctors can help improve their experience and outcomes.
-
Effects of Ertugliflozin on liver fat and diabetes control in patients with fatty liver disease
This study is testing if the medication Ertugliflozin can help adults with Type 2 Diabetes and fatty liver disease reduce liver fat and improve their blood sugar control.
-
Using a special airway device to treat sleep apnea in children with weak muscles
This study is testing a special airway device to see if it can help children with weak muscles who have sleep apnea breathe better at night without needing surgery.
-
Combined kidney and blood stem cell transplant from a sibling donor
This study is testing a new treatment for kidney transplant recipients to see if using a sibling's blood stem cells can help them accept their new kidney without needing lifelong medications to prevent rejection.
Related topics
Quick answers
How many Tolerance clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (3 trials), France (1 trial), Pakistan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Early Phase 1: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.